Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients - Discussion - Dr. Nutt

被引：0
|
作者：
Obeso
Nutt
Reichmann
Olanow
Lieberman
Koller
Fahn
Gordin
Waters
Dingemanse
Reichmann
Brooks
Guttman
Hauser
机构：
来源：
NEUROLOGY | 2000年 / 55卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S38 / S41
页数：4
相关论文
共 50 条
  • [31] Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease - Implications for the early use of COMT inhibitors - Discussion - Dr. Olanow
    Rascol
    Obeso
    Stocchi
    Jenner
    Olanow
    Stocchi
    Schapira
    Koller
    LeWitt
    Waters
    [J]. NEUROLOGY, 2000, 55 (11) : S78 - S81
  • [32] The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease - Discussion - Dr. Schapira
    Schapira
    Fahn
    Olanow
    Dingemanse
    Waters
    Korczyn
    Gordin
    Koller
    Obeso
    Jenner
    Rascol
    [J]. NEUROLOGY, 2000, 55 (11) : S69 - S71
  • [33] Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients
    Brefel, C
    Thalamas, C
    Rayet, S
    Lopez-Gil, A
    Fitzpatrick, K
    Bullman, S
    Citerone, DR
    Taylor, AC
    Montastruc, JL
    Rascol, O
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (04) : 412 - 415
  • [34] The effect of catechol-O-methyltransferase polymorphism on the levodopa pharmacokinetics after co-administration of single dose of levodopa and entacapone in Parkinsonian patients
    Wu, RM
    Yu, IW
    Ho, YF
    Kuo, JW
    Chern, H
    [J]. MOVEMENT DISORDERS, 2002, 17 : S50 - S51
  • [35] Effect of levodopa on orthostatic and postprandial hypotension in elderly parkinsonian patients
    Mehagnoul-Schipper, DJ
    Boerman, RH
    Hoefnagels, WHL
    Jansen, RWMM
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2001, 56 (12): : M749 - M755
  • [36] EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS
    AHTILA, S
    KAAKKOLA, S
    GORDIN, A
    KORPELA, K
    HEINAVAARA, S
    KARLSSON, M
    WIKBERG, T
    TUOMAINEN, P
    MANNISTO, PT
    [J]. CLINICAL NEUROPHARMACOLOGY, 1995, 18 (01) : 46 - 57
  • [37] The Impact of COMT-inhibition on Gastrointestinal Levodopa Absorption in Patients with Parkinson's Disease
    Mueller, Thomas
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 155 - 168
  • [38] Effect of MTHFR Polymorphisms on Hyperhomocysteinemia in Levodopa-treated Parkinsonian Patients
    D. Caccamo
    G. Gorgone
    M. Currò
    G. Parisi
    W. Di Iorio
    C. Menichetti
    V. Belcastro
    L. Parnetti
    A. Rossi
    F. Pisani
    R. Ientile
    P. Calabresi
    [J]. NeuroMolecular Medicine, 2007, 9 : 249 - 254
  • [39] INFLUENCE OF MEAL INGESTION TIME ON PHARMACOKINETICS OF ORALLY-ADMINISTERED LEVODOPA IN PARKINSONIAN-PATIENTS
    BARUZZI, A
    CONTIN, M
    RIVA, R
    PROCACCIANTI, G
    ALBANI, F
    TONELLO, C
    ZONI, E
    MARTINELLI, P
    [J]. CLINICAL NEUROPHARMACOLOGY, 1987, 10 (06) : 527 - 537
  • [40] Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients
    Caccamo, D.
    Gorgone, G.
    Curro, M.
    Parisi, G.
    Di Iorio, W.
    Menichetti, C.
    Belcastro, V.
    Parnetti, L.
    Rossi, A.
    Pisani, F.
    Ientile, R.
    Calabresi, P.
    [J]. NEUROMOLECULAR MEDICINE, 2007, 9 (03) : 249 - 254
12345